Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese Persons
Clinical trial NCT06515834 · COMPLETED
Trial details
- NCT number
- NCT06515834
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2024-11-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.